×
OSR Holdings Pre-Tax Profit Margin 2023-2025 | OSRH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
OSR Holdings pre-tax profit margin from 2023 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
View More
OSR Holdings Pre-Tax Profit Margin 2023-2025 | OSRH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
OSR Holdings pre-tax profit margin from 2023 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$138B
CVS Health (CVS)
$80.9B
Elevance Health (ELV)
$76B
Cencora (COR)
$57.1B
DiDi Global (DIDIY)
$25.8B
Labcorp Holdings (LH)
$20.6B
Natera (NTRA)
$20.5B
BioMerieux (BMXMF)
$16.9B
EUROFINS SCIENT (ERFSF)
$13.6B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.7B
ICON (ICLR)
$11.8B
Revvity (RVTY)
$11.3B
Viatris (VTRS)
$10.5B
Medpace Holdings (MEDP)
$9B
Sonic Healthcare (SKHHY)
$8.8B
Avantor (AVTR)
$8.7B
HealthEquity (HQY)
$8.3B
Charles River Laboratories (CRL)
$7.6B
Caris Life Sciences,�Inc (CAI)
$7.4B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$4.9B
BrightSpring Health Services (BTSG)
$3.5B
Sotera Health (SHC)
$3.2B
Surgery Partners (SGRY)
$2.8B
Alignment Healthcare (ALHC)
$2.6B
Concentras Parent (CON)
$2.5B
Organon (OGN)
$2.5B
GeneDx Holdings (WGS)
$2.3B
Progyny (PGNY)
$2B